Status:
WITHDRAWN
Novel Guidance Device for Image Fusion and Needle Guidance in Lung, Liver or Kidney Biopsy
Lead Sponsor:
Clear Guide Medical
Collaborating Sponsors:
Temple University
National Institutes of Health (NIH)
Conditions:
Liver Biopsy
Lung Biopsy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study investigates whether a new image fusion technology can reduce patient radiation dose from CTs and/or procedure time during biopsies of lung, liver or kidney.
Detailed Description
This study proposes the use of a new fusion technology, Scenergy (Clear Guide Medical; FDA 510(k) K171677), which fuses CT images to real-time US images to minimize the drawbacks of each modality whil...
Eligibility Criteria
Inclusion
- all patients between the ages of 18 and 80 years old at time of procedure who are pre-scheduled for a lung, kidney, or liver biopsy.
Exclusion
- any patient who was under the age of 18 or over the age of 80 at time of the procedure or who does not wish to volunteer for the study.
Key Trial Info
Start Date :
December 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04039529
Start Date
December 31 2019
End Date
December 31 2020
Last Update
February 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Temple University Hospital
Philadelphia, Pennsylvania, United States, 19140